The generation of transgenic pigs as potential organ donors for humans (original) (raw)

References

1. Cooper, D.K.C., Ye, Y., Rolf, J.L.L. & Zuhdi, N. The pig as potential organ donor for man in Xenotransplantation: The Transplantation of Organs and Tissues Between Species (eds Cooper, D.K.C., Kemp, E., Reemtsma, K. & White, D.J.G.) 481–500 (Springer, Berlin, 1991).
   Google Scholar
2. Calne, R.Y. Organ transplantation between widely disparate species. Transplants Proc. 2, 550–553 (1970).
   CAS Google Scholar
3. Sachs, D.H. & Bach, F.H. Immunology of xenograft rejection. Hum. Immun. 28, 245–251 (1990).
   Article CAS Google Scholar
4. Dalmasso, A.P. et al. Mechanisms of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140, 1157–1166 (1992).
   CAS PubMed PubMed Central Google Scholar
5. Johnston, P.S., Wang, M.W., Lim, S.M., Wright, L.J. & White, D.J. Discordant xenograft rejection in an antibody-free model. Transplantation 54, 573–576 (1992).
   Article CAS Google Scholar
6. Platt, J.L. et al. Immunopathology of hyperacute rejection in a swine to primate model. Transplantation 52, 214–220 (1991).
   Article CAS Google Scholar
7. Kemp, E., Kemp, G., Starklint, H. & Larsen, S. Immunosuppression with cobra venom factor, anti-platelet aggregator, and cyclosporin A in renal xenotransplantation. Transplantn Proc. 14, 116 (1982).
   Google Scholar
8. Braidley, P.C., Dunning, J.J., Wallwork, J. & White, D.J.G. Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs. Transplantn Proc. 26, 1259–1260 (1994).
   CAS Google Scholar
9. Leventhal, J.R. et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55, 857–865 (1993).
   Article CAS Google Scholar
10. Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363–370 (1994).
    Article CAS Google Scholar
11. Lachmann, P.J. The control of homologous lysis. Immun. Today. 12, 312–315 (1991).
    Article CAS Google Scholar
12. Atkinson, J.P., Odlesby, T.J., White, D.J.G., Adams, E.A. & Liszewski, M.K. Separation of self from non self in the complement system. A role for membrane cofactor protein and decay accelerating factor. Clin. exp. Immun. 86, 27–30 (1991).
    Article CAS Google Scholar
13. Oglesby, T.J., Allen, C.J., Liszewski, M.K., White, D.J. & Atkinson, J.P. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J. exp. Med. 175, 1547–1551 (1992).
    Article CAS Google Scholar
14. White, D.J.G. et al. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant. Int. 5, 648–650 (1992).
    Article Google Scholar
15. Dalmasso, A.P., Vercelloti, G.M., Platt, J.L. & Bach, F.H. Inhibition of complement mediated cytotoxicity by decay accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52, 530–533 (1991).
    Article CAS Google Scholar
16. Cary, N., Moody, J., Yannoutsos, N., Wallwork, J. & White, D. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: A potential approach to inhibition of hyperacute xenograft rejection. Transplantn Proc. 25, 400–401 (1993).
    CAS Google Scholar
17. Diamond, L. et al. Cell and tissue specific expression of a human CD59 minigene in transgenic mice. Transplantn Proc. 26, 1239 (1994).
    CAS Google Scholar
18. Rosengard, A.M. et al. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs — a potential approach for preventing xenograft rejection. Transplantation 59, 1325–1333 (1995).
    Article CAS Google Scholar
19. Fodor, W.L. et al. Expression of a functional human complement inhibitor in transgenic swine as an approach to prevent xenogeneic hyperacute organ rejection. Proc. natn. Acad. Sci. USA. 91, 11153–11157 (1994).
    Article CAS Google Scholar
20. Miyagawa, S. et al. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium. Transplantn Proc. 26, 1253–1254 (1994).
    CAS Google Scholar
21. Walsh, L.A., Tone, M. & Waldmann, H. Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement. Eur. J. Immun. 21, 847–850 (1991).
    Article CAS Google Scholar
22. Charreau, B. et al. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation 58, 1222–1229 (1994).
    CAS PubMed Google Scholar
23. Van den Berg, C.W. & Morgan, B.P. Complement-inhibiting activities of human CD59 and analogues from rat, sheep and pig are not homologously restricted. J. Immun. 152, 4095–4101 (1995).
    Google Scholar
24. Langford, G.A. et al. Production of pigs transgenic for human decay accelerating factor. Transplantn Proc. 26, 1400–1401 (1994).
    CAS Google Scholar
25. White, D.J.G., Langford, G.A., Cozzi, E. & Young, V.J. Protective effects of human DAF in transgenic pigs. Xeno (in the press).
26. McCurry, K.R. et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1, 423–427 (1995).
    Article CAS Google Scholar
27. Bach, F.H. et al. Discordant xenografting: A working model of problems and issues. Xeno 1, 8–15 (1993).
    Google Scholar
28. Cooper, D.K.C., Koren, E. & Oriol, R. Oligosaccharides and discordant xenotransplantation. Immunol. Rev. 141, 31–58 (1994).
    Article CAS Google Scholar
29. Sandrin, M.S., Vaughan, H.A. & McKenzie, I.F.C. Identification of Galα(l–3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplantn Rev. 8, 134–149 (1994).
    Article Google Scholar
30. Yannoutsos, N. et al. Production of pigs transgenic for human regulators of complement activation. Transplantn Proc. 27, 324–325 (1995).
    CAS Google Scholar

Download references